R&D
Novo Nordisk to expand Beijing R&D centre
September 25, 2012Research and Development, Sales and Marketing Beijing, China, Novo Nordisk, R&D
Novo Nordisk is investing $100 million into enlarging its R&D facilities in Beijing into a state-of-the-art centre. Located in the …
Pharma creates non-profit R&D organisation
September 21, 2012Research and Development, Sales and Marketing Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Co, GlaxoSmithKline, Johnson & Johnson, Pfizer, R&D, Roche Genentech, Sanofi, TransCelerate BioPharma, biopharma
Ten biopharma companies have formed TransCelerate BioPharma Inc, a not-for-profit organisation using money and personnel from each firm, with a …
J&J sets up life science centres
September 19, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, R&D, innovation
Johnson & Johnson is to set up what it calls regional innovation centres in a bid to speed up the …
UCB opens Belgian pilot plant
September 17, 2012Manufacturing and Production Amgen, Belgium, R&D, UCB
UCB has officially opened a new pilot biotech plant at its Braine-L’Alleud site in Belgium.The 5,100 sq. m. facility – …
Acino plant opens to serve Bayer contraceptive patch needs
August 14, 2012Manufacturing and Production Acino, Bayer, R&D, Swiss, contraceptive
Acino has officially opened its new manufacturing facility for transdermal patch products in Miesbach, Germany, which it says makes it …
Novartis pledges to maintain R&D presence in Horsham
August 14, 2012Manufacturing and Production, Research and Development Horsham, NIBR, Novartis, R&D, cuts
Novartis has confirmed that it intends to maintain a presence at its site in Horsham, UK, which has already seen …
Avastin sees success in brain cancer trial
August 13, 2012Research and Development, Sales and Marketing R&D, avastin, brain cancer
A late-stage study has shown that Roche’s oncology drug Avastin, when added to standard therapy, can help people with brain …
Torisel-Avastin combo fails in kidney cancer
August 13, 2012Research and Development, Sales and Marketing R&D, Sutent, Torisel, avastin, failure, rcc
Combining Pfizer’s Torisel and Roche’s Avastin does not increase survival rates for advanced kidney cancer patients. This is according to …
Pfizer Sandwich site sold to private consortium
August 3, 2012Business Services, Research and Development, Sales and Marketing Jobs, Pfizer, R&D, Sandwich, cuts
The Sandwich Discovery Park in Kent has found new owners, 18 months after Pfizer decided to pull out from the …
Government to harness NHS patient data for research use
August 2, 2012Sales and Marketing NHS, R&D, UK, david cameron, innovation, real world data
The UK government will change the NHS Constitution in order to allow patients’ data to be used for research purposes. …
AstraZeneca launches virtual research laboratory
July 31, 2012Medical Communications Assay Depot, AstraZeneca, R&D, virtual
AstraZeneca and partner Assay Depot have launched a virtual research laboratory aimed at helping its scientists create R&D collaborations. The …
Parexel’s BioPharm Unit to aid smaller R&D firms
July 25, 2012Research and Development Parexel, R&D, biotech
Parexel has launched the Parexel BioPharm Unit – a new division focused on the needs of small and mid-sized biopharma …
GSK raises stake in Amicus for Fabry drug
July 18, 2012Research and Development, Sales and Marketing Amicus, Fabry, GSK, R&D
GlaxoSmithKline is to increase ownership in Amicus Therapeutics as the firms extend their collaboration to find a new drug for …
Glaxo seals $3 billion acquisition of HGS
July 17, 2012Business Services, Research and Development, Sales and Marketing Benlysta, GSK, Human Genome Sciences, R&D
GlaxoSmithKline has finally sealed the acquisition of Human Genome Sciences, the company with which it co-markets lupus treatment Benlysta. The …
Jobs under threat in Actelion cost saving
July 12, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Actelion, R&D, Tracleer, cuts
Swiss speciality pharmaceutical company Actelion has unveiled a new cost saving plan which could include the loss of 260 jobs …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
